USANA Health Sciences, Inc.
General ticker "USNA" information:
- Sector: Consumer Staples
- Industry: Packaged Foods
- Capitalization: $558.4M (TTM average)
USANA Health Sciences, Inc. does not follow the US Stock Market performance with the rate: -9.5%.
Estimated limits based on current volatility of 2.0%: low 16.96$, high 17.66$
Factors to consider:
- Total employees count: 1700 (-5.6%) as of 2024
- China accounted for 48.4% of revenue in the fiscal year ended 2024-12-28
- US accounted for 10.7% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Manufacturing disruptions, Cybersecurity threats, Geopolitical risks, Economic downturns and volatility, Product liability
- Current price 27.6% below estimated low
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-28 to 2026-12-28
- 2024-12-28 to 2025-12-28 estimated range: [26.20$, 44.21$]
- 2025-12-28 to 2026-12-28 estimated range: [24.23$, 41.14$]
Financial Metrics affecting the USNA estimates:
- Positive: with PPE of 13.6 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 7.76
- Positive: 6.64 < Operating cash flow per share per price, % of 9.02
- Negative: 0.01 < Interest expense per share per price, % of 0.04
- Negative: Industry operating cash flow per share per price (median), % of 1.34 <= 5.46
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.31
- Positive: Shareholder equity ratio, % of 71.12 > 64.29
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Inventory ratio change, % of 1.42 > 0.80
Short-term USNA quotes
Long-term USNA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-28 |
|---|---|---|---|
| Operating Revenue | $998.60MM | $921.01MM | $854.50MM |
| Operating Expenses | $890.99MM | $827.94MM | $788.18MM |
| Operating Income | $107.61MM | $93.07MM | $66.32MM |
| Non-Operating Income | $1.01MM | $9.38MM | $10.03MM |
| Interest Expense | $0.19MM | $0.26MM | $0.28MM |
| R&D Expense | $0.00MM | $11.45MM | $0.00MM |
| Income(Loss) | $108.62MM | $102.45MM | $76.35MM |
| Taxes | $39.27MM | $38.66MM | $34.29MM |
| Profit(Loss)* | $69.35MM | $63.79MM | $42.03MM |
| Stockholders Equity | $434.47MM | $497.20MM | $532.11MM |
| Inventory | $67.09MM | $61.45MM | $69.73MM |
| Assets | $596.55MM | $632.76MM | $748.19MM |
| Operating Cash Flow | $103.90MM | $70.64MM | $60.99MM |
| Capital expenditure | $10.40MM | $14.49MM | $10.07MM |
| Investing Cash Flow | $-12.37MM | $-11.97MM | $-213.09MM |
| Financing Cash Flow | $-30.09MM | $-14.24MM | $9.55MM |
| Earnings Per Share** | $3.60 | $3.31 | $2.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.